The Yale Center for Immuno-Oncology builds on Yale Cancer Center and Smilow Cancer Hospital’s international leadership in immunobiology, cancer immunology, and the development of novel cancer immunotherapies to effectively broaden our translational research infrastructure.
Please join us for a day-long symposium highlighting advancements in immuno-oncology and featuring leaders in immunology from around the country for presentations, discussion, and networking.
Yale Center for Immuno-Oncology Symposium Agenda
Friday, October 11, 2019
Harkness Auditorium
08:30 - 09:00 Registration and Breakfast
09:00 - 09:15 Opening remarks
Charles S. Fuchs, MD, MPH, Director, Yale Cancer Center; Physician-in-Chief, Smilow Cancer Hospital
David Schatz, PhD, Chair, Department of Immunobiology
Roy S. Herbst, MD, PhD, Chief of Medical Oncology; Associate Director for Translational Research; Ensign Professor of Medicine
Marcus Bosenberg, MD, PhD, Professor of Dermatology, Pathology, and Immunobiology, Co-Leader, Genetics, Genomics and Epigenetics Research Program; Interim Director, Yale Cancer for Immuno-Oncology
Visualizing tumor immunity and response
09:15 – 10:15 Anna Wu, PhD, Professor and Chair, Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope
10:15 – 10:45 David Rimm, MD, PhD, Professor of Pathology and of Medicine, Yale School of Medicine
10:45 – 11:00 Coffee break
Taming the tumor microenvironment ecosystem
11:00 – 12:00 Greg M. Delgoffe, PhD, Assistant Professor, Immunology, University of Pittsburgh
12:00 – 1:00 Drew Mark Pardoll, MD, PhD, Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy, Abeloff Professor of Oncology, Johns Hopkins University
1:00 – 2:00 Lunch
Improving therapeutic success
2:00-3:00 Cornelia Liu Trimble, MD, Professor of Gynecology and Obstetrics, Oncology and Pathology, Johns Hopkins School of Medicine
3:00-3:30 Katerina Politi, PhD, Associate Professor of Pathology, Yale Cancer Center
3:30-3:45 Coffee break
Developing Novel and Cell-Based Therapies
3:45-4:15 Lieping Chen, MD, PhD, United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, Dermatology and Medicine (Medical Oncology), Yale School of Medicine
4:15-4:45 Mario Sznol, MD, Professor of Medicine (Medical Oncology), Yale Cancer Center
4:45-4:50 Closing remarks
Roy S. Herbst, MD, PhD, Chief of Medical Oncology; Associate Director for Translational Research; Ensign Professor of Medicine
Marcus Bosenberg, MD, PhD, Professor of Dermatology, Pathology, and Immunobiology, Co-Leader, Genetics, Genomics and Epigenetics Research Program; Interim Director, Yale Cancer for Immuno-Oncology